Fan Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fan Yang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Lin Chen
Department of Public Health Sciences, The University of Chicago, Chicago, IL, USA
4 shared publications Shuozhi Zuo
Department of Statistics University of Michigan Ann Arbor
4 shared publications- Debashis Ghosh
Department of Biostatistics & Informatics, University of Colorado-Anschutz Medical Campus , Aurora, Colorado
3 shared publications Kevin J. Gleason
Department of Public Health Sciences University of Chicago Chicago Illinois USA
3 shared publications- Peng Ding
Department of Statistics, University of California, Berkeley
3 shared publications - Kevin P. Josey
US Department of Veterans Affairs Eastern Colorado Health Care System , Aurora, CO
2 shared publications
Latest Publications
- Open Access
Identification and estimation of the conditional average treatment effect with nonignorable missing covariates, treatment, and outcome
Treatment effect heterogeneity is central to policy evaluation, social science, and precision medicine, where interventions can affect individuals differently. In observational studies, covariates, treatment, and outcomes are often only partially observed. When missingness depends on unobserved values (missing not at random; MNAR), standard methods can yield biased estimates of the conditional average treatment effect (CATE). This paper establishes nonparametric identification of the CATE under multivariate MNAR mechanisms that allow covariates, treatment, and outcomes to be MNAR. It also develops nonparametric and parametric estimators and proposes a sensitivity analysis framework for assessing robustness to violations of the missingness assumptions.
Open AccessIdentification and estimation of the conditional average treatment effect with nonignorable missing covariates, treatment, and outcome
Treatment effect heterogeneity is central to policy evaluation, social science, and precision medicine, where interventions can affect individuals differently. In observational studies, covariates, treatment, and outcomes are often only partially observed. When missingness depends on unobserved values (missing not at random; MNAR), standard methods can yield biased estimates of the conditional average treatment effect (CATE). This paper establishes nonparametric identification of the CATE under multivariate MNAR mechanisms that allow covariates, treatment, and outcomes to be MNAR. It also develops nonparametric and parametric estimators and proposes a sensitivity analysis framework for assessing robustness to violations of the missingness assumptions.
- Open Access
Identifiability of the instrumental variable model with the treatment and outcome missing not at random
The instrumental variable model of Imbens and Angrist (1994) and Angrist et al. (1996) allow for the identification of the local average treatment effect, also known as the complier average causal effect. However, many empirical studies are challenged by the missingness in the treatment and outcome. Generally, the complier average causal effect is not identifiable without further assumptions when the treatment and outcome are missing not at random. We study its identifiability even when the treatment and outcome are missing not at random. We review the existing results and provide new findings to unify the identification analysis in the literature.
Open AccessIdentifiability of the instrumental variable model with the treatment and outcome missing not at random
The instrumental variable model of Imbens and Angrist (1994) and Angrist et al. (1996) allow for the identification of the local average treatment effect, also known as the complier average causal effect. However, many empirical studies are challenged by the missingness in the treatment and outcome. Generally, the complier average causal effect is not identifiable without further assumptions when the treatment and outcome are missing not at random. We study its identifiability even when the treatment and outcome are missing not at random. We review the existing results and provide new findings to unify the identification analysis in the literature.
- 1 September 2024
- Published by Institute of Mathematical Statistics in The Annals of Applied Statistics
- Vol. 18 (3) , 2656-2677
Integrating Mendelian randomization with causal mediation analyses for characterizing direct and indirect exposure-to-outcome effects
Mendelian randomization (MR) assesses the total effect of exposure on outcome. With the rapidly increasing availability of summary statistics from genome-wide association studies (GWASs), MR leverages existing summary statistics and is widely used to study the causal effects among complex traits and diseases. The total effect in the population is a sum of indirect and direct effects. For complex disease outcomes with complicated etiologies and/or for modifiable exposure traits, there may exist more than one pathway between exposure and outcome. The direct effect and the indirect effect via a mediator of interest could be in opposite directions, and the total effect estimates may not be informative for treatment and prevention decision-making or may even be misleading for different subgroups of patients. Causal mediation analysis delineates the indirect effect of exposure on outcome operating through the mediator and the direct effect transmitted through other mechanisms. However, causal mediation analysis often requires individual-level data measured on exposure, outcome, mediator and confounding variables, and the power of the mediation analysis is restricted by sample size. In this work, motivated by a study of the effects of atrial fibrillation (AF) on Alzheimer’s dementia, we propose a framework for Integrative Mendelian randomization and Mediation Analysis (IMMA). The proposed method integrates the total effect estimates from MR analyses based on large-scale GWASs with the direct and indirect effect estimates from mediation analysis based on individual-level data of a limited sample size. We introduce a series of IMMA models under the scenarios with or without exposure-mediator interaction and/or study heterogeneity. The proposed IMMA models improve the estimation and the power of inference on the direct and indirect effects in the population. Our analyses showed a significant positive direct effect of AF on Alzheimer’s dementia risk not through the use of the oral anticoagulant treatment and a significant indirect effect of AF-induced anticoagulant treatment in reducing Alzheimer’s dementia risk. The results suggested potential Alzheimer’s dementia risk prediction and prevention strategies for AF patients and paved the way for future reevaluation of anticoagulant treatment guidelines for AF patients. A sensitivity analysis was conducted to assess the sensitivity of the conclusions to a key assumption of the IMMA approach.
- 1 September 2024
- Published by Institute of Mathematical Statistics in The Annals of Applied Statistics
- Vol. 18 (3) , 2656-2677
Integrating Mendelian randomization with causal mediation analyses for characterizing direct and indirect exposure-to-outcome effects
Mendelian randomization (MR) assesses the total effect of exposure on outcome. With the rapidly increasing availability of summary statistics from genome-wide association studies (GWASs), MR leverages existing summary statistics and is widely used to study the causal effects among complex traits and diseases. The total effect in the population is a sum of indirect and direct effects. For complex disease outcomes with complicated etiologies and/or for modifiable exposure traits, there may exist more than one pathway between exposure and outcome. The direct effect and the indirect effect via a mediator of interest could be in opposite directions, and the total effect estimates may not be informative for treatment and prevention decision-making or may even be misleading for different subgroups of patients. Causal mediation analysis delineates the indirect effect of exposure on outcome operating through the mediator and the direct effect transmitted through other mechanisms. However, causal mediation analysis often requires individual-level data measured on exposure, outcome, mediator and confounding variables, and the power of the mediation analysis is restricted by sample size. In this work, motivated by a study of the effects of atrial fibrillation (AF) on Alzheimer’s dementia, we propose a framework for Integrative Mendelian randomization and Mediation Analysis (IMMA). The proposed method integrates the total effect estimates from MR analyses based on large-scale GWASs with the direct and indirect effect estimates from mediation analysis based on individual-level data of a limited sample size. We introduce a series of IMMA models under the scenarios with or without exposure-mediator interaction and/or study heterogeneity. The proposed IMMA models improve the estimation and the power of inference on the direct and indirect effects in the population. Our analyses showed a significant positive direct effect of AF on Alzheimer’s dementia risk not through the use of the oral anticoagulant treatment and a significant indirect effect of AF-induced anticoagulant treatment in reducing Alzheimer’s dementia risk. The results suggested potential Alzheimer’s dementia risk prediction and prevention strategies for AF patients and paved the way for future reevaluation of anticoagulant treatment guidelines for AF patients. A sensitivity analysis was conducted to assess the sensitivity of the conclusions to a key assumption of the IMMA approach.
- Open Access
- 26 June 2024
- Published by Taylor & Francis in Journal of the American Statistical Association
- Vol. 120 (550) , 794-804
Mediation Analysis with the Mediator and Outcome Missing Not at Random
Mediation analysis is widely used for investigating direct and indirect causal pathways through which an effect arises. However, many mediation analysis studies are challenged by missingness in the mediator and outcome. In general, when the mediator and outcome are missing not at random, the direct and indirect effects are not identifiable without further assumptions. We study the identifiability of the direct and indirect effects under some interpretable mechanisms that allow for missing not at random in the mediator and outcome. We evaluate the performance of statistical inference under those mechanisms through simulation studies and illustrate the proposed methods via the National Job Corps Study.
- 26 June 2024
- Published by Taylor & Francis in Journal of the American Statistical Association
- Vol. 120 (550) , 794-804
Open AccessMediation Analysis with the Mediator and Outcome Missing Not at Random
Mediation analysis is widely used for investigating direct and indirect causal pathways through which an effect arises. However, many mediation analysis studies are challenged by missingness in the mediator and outcome. In general, when the mediator and outcome are missing not at random, the direct and indirect effects are not identifiable without further assumptions. We study the identifiability of the direct and indirect effects under some interpretable mechanisms that allow for missing not at random in the mediator and outcome. We evaluate the performance of statistical inference under those mechanisms through simulation studies and illustrate the proposed methods via the National Job Corps Study.
- Open Access
Mediation analysis with the mediator and outcome missing not at random
Mediation analysis is widely used for investigating direct and indirect causal pathways through which an effect arises. However, many mediation analysis studies are challenged by missingness in the mediator and outcome. In general, when the mediator and outcome are missing not at random, the direct and indirect effects are not identifiable without further assumptions. In this work, we study the identifiability of the direct and indirect effects under some interpretable mechanisms that allow for missing not at random in the mediator and outcome. We evaluate the performance of statistical inference under those mechanisms through simulation studies and illustrate the proposed methods via the National Job Corps Study.
Open AccessMediation analysis with the mediator and outcome missing not at random
Mediation analysis is widely used for investigating direct and indirect causal pathways through which an effect arises. However, many mediation analysis studies are challenged by missingness in the mediator and outcome. In general, when the mediator and outcome are missing not at random, the direct and indirect effects are not identifiable without further assumptions. In this work, we study the identifiability of the direct and indirect effects under some interpretable mechanisms that allow for missing not at random in the mediator and outcome. We evaluate the performance of statistical inference under those mechanisms through simulation studies and illustrate the proposed methods via the National Job Corps Study.
- 7 August 2023
- Published by Wiley in Statistics in Medicine
- Vol. 42 (24) , 4349-4376
Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low‐income adults
Medical cost data often consist of zero values as well as extremely right‐skewed positive values. A two‐part model is a popular choice for analyzing medical cost data, where the first part models the probability of a positive cost using logistic regression and the second part models the positive cost using a lognormal or Gamma distribution. To address the unmeasured confounding in studies on cost outcome under two‐part models, two instrumental variable (IV) methods, two‐stage residual inclusion (2SRI) and two‐stage prediction substitution (2SPS) are widely applied. However, previous literature demonstrated that both the 2SRI and the 2SPS could fail to consistently estimate the causal effect among compliers under standard IV assumptions for binary and survival outcomes. Our simulation studies confirmed that it continued to be the case for a two‐part model, which is another nonlinear model. In this article, we develop a model‐based IV approach, Instrumental Variable with Two‐Part model (IV2P), to obtain a consistent estimate of the causal effect among compliers for cost outcome under standard IV assumptions. In addition, we develop sensitivity analysis approaches to allow the evaluation of the sensitivity of the causal conclusions to potential quantified violations of the exclusion restriction assumption and the randomization of IV assumption. We apply our method to a randomized cash incentive study to evaluate the effect of a primary care visit on medical cost among low‐income adults newly covered by a primary care program.
- 7 August 2023
- Published by Wiley in Statistics in Medicine
- Vol. 42 (24) , 4349-4376
Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low‐income adults
Medical cost data often consist of zero values as well as extremely right‐skewed positive values. A two‐part model is a popular choice for analyzing medical cost data, where the first part models the probability of a positive cost using logistic regression and the second part models the positive cost using a lognormal or Gamma distribution. To address the unmeasured confounding in studies on cost outcome under two‐part models, two instrumental variable (IV) methods, two‐stage residual inclusion (2SRI) and two‐stage prediction substitution (2SPS) are widely applied. However, previous literature demonstrated that both the 2SRI and the 2SPS could fail to consistently estimate the causal effect among compliers under standard IV assumptions for binary and survival outcomes. Our simulation studies confirmed that it continued to be the case for a two‐part model, which is another nonlinear model. In this article, we develop a model‐based IV approach, Instrumental Variable with Two‐Part model (IV2P), to obtain a consistent estimate of the causal effect among compliers for cost outcome under standard IV assumptions. In addition, we develop sensitivity analysis approaches to allow the evaluation of the sensitivity of the causal conclusions to potential quantified violations of the exclusion restriction assumption and the randomization of IV assumption. We apply our method to a randomized cash incentive study to evaluate the effect of a primary care visit on medical cost among low‐income adults newly covered by a primary care program.
- Open Access
An empirical process framework for covariate balance in causal inference
We propose a new perspective for the evaluation of matching procedures by considering the complexity of the function class they belong to. Under this perspective we provide theoretical guarantees on post-matching covariate balance through a finite sample concentration inequality. We apply this framework to coarsened exact matching as well as matching using the propensity score and suggest how to apply it to other algorithms. Simulation studies are used to evaluate the procedures.
Open AccessAn empirical process framework for covariate balance in causal inference
We propose a new perspective for the evaluation of matching procedures by considering the complexity of the function class they belong to. Under this perspective we provide theoretical guarantees on post-matching covariate balance through a finite sample concentration inequality. We apply this framework to coarsened exact matching as well as matching using the propensity score and suggest how to apply it to other algorithms. Simulation studies are used to evaluate the procedures.
- 1 December 2022
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 6 (6) , e2200088
Transportability Methods for Time-to-Event Outcomes: Application in Adjuvant Colon Cancer Trials
PURPOSE: Differences in the benefits of treatment on 5-year overall survival have been observed in 12 randomized phase III colon cancer adjuvant clinical trials from the ACCENT group. We investigated the reasons for these differences by incorporating the distribution of the observed covariates from each trial.MATERIALS AND METHODS: We applied state-of-the-art transportability methods on the basis of causal inference, and compared them with a conventional meta-analysis approach to predict the treatment effect for the target population. Prediction errors were defined to evaluate whether the identifiability conditions necessary for causal inference were satisfied among the 12 trials, and to measure the performance of each method.RESULTS: In the one-trial-at-a-time transportability analysis, the ranks of prediction errors for the target population were mostly consistent with the discrepancy in treatment effects among the 12 trials across the three models. The overall prediction errors between the leave-one-trial-out transportability method and the conventional individual participant data meta-analysis approach were very similar, and more than 40% lower than the overall prediction errors from the one-trial-at-a-time transportability method.CONCLUSION: The discrepancy in treatment effects among the 12 trials is unlikely to arise from the choice of model specification or distribution of observed covariates but from the distribution of unobserved covariates or study-level features. The ability to quantify heterogeneity among the 12 trials was greatly reduced in both the leave-one-trial-out transportability method and the conventional meta-analysis approach compared with the one-trial-at-a-time transportability method.
- 1 December 2022
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 6 (6) , e2200088
Transportability Methods for Time-to-Event Outcomes: Application in Adjuvant Colon Cancer Trials
PURPOSE: Differences in the benefits of treatment on 5-year overall survival have been observed in 12 randomized phase III colon cancer adjuvant clinical trials from the ACCENT group. We investigated the reasons for these differences by incorporating the distribution of the observed covariates from each trial.MATERIALS AND METHODS: We applied state-of-the-art transportability methods on the basis of causal inference, and compared them with a conventional meta-analysis approach to predict the treatment effect for the target population. Prediction errors were defined to evaluate whether the identifiability conditions necessary for causal inference were satisfied among the 12 trials, and to measure the performance of each method.RESULTS: In the one-trial-at-a-time transportability analysis, the ranks of prediction errors for the target population were mostly consistent with the discrepancy in treatment effects among the 12 trials across the three models. The overall prediction errors between the leave-one-trial-out transportability method and the conventional individual participant data meta-analysis approach were very similar, and more than 40% lower than the overall prediction errors from the one-trial-at-a-time transportability method.CONCLUSION: The discrepancy in treatment effects among the 12 trials is unlikely to arise from the choice of model specification or distribution of observed covariates but from the distribution of unobserved covariates or study-level features. The ability to quantify heterogeneity among the 12 trials was greatly reduced in both the leave-one-trial-out transportability method and the conventional meta-analysis approach compared with the one-trial-at-a-time transportability method.
- Open Access
- 1 June 2022
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 79 (2) , 1042-1056
Posttreatment Confounding in Causal Mediation Studies: A Cutting-Edge Problem and a Novel Solution via Sensitivity Analysis
In causal mediation studies that decompose an average treatment effect into indirect and direct effects, examples of posttreatment confounding are abundant. In the presence of treatment-by-mediator interactions, past research has generally considered it infeasible to adjust for a posttreatment confounder of the mediator–outcome relationship due to incomplete information: for any given individual, a posttreatment confounder is observed under the actual treatment condition while missing under the counterfactual treatment condition. This paper proposes a new sensitivity analysis strategy for handling posttreatment confounding and incorporates it into weighting-based causal mediation analysis. The key is to obtain the conditional distribution of the posttreatment confounder under the counterfactual treatment as a function of not only pretreatment covariates but also its counterpart under the actual treatment. The sensitivity analysis then generates a bound for the natural indirect effect and that for the natural direct effect over a plausible range of the conditional correlation between the posttreatment confounder under the actual and that under the counterfactual conditions. Implemented through either imputation or integration, the strategy is suitable for binary as well as continuous measures of posttreatment confounders. Simulation results demonstrate major strengths and potential limitations of this new solution. A reanalysis of the National Evaluation of Welfare-to-Work Strategies (NEWWS) Riverside data reveals that the initial analytic results are sensitive to omitted posttreatment confounding.
- 1 June 2022
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 79 (2) , 1042-1056
Open AccessPosttreatment Confounding in Causal Mediation Studies: A Cutting-Edge Problem and a Novel Solution via Sensitivity Analysis
In causal mediation studies that decompose an average treatment effect into indirect and direct effects, examples of posttreatment confounding are abundant. In the presence of treatment-by-mediator interactions, past research has generally considered it infeasible to adjust for a posttreatment confounder of the mediator–outcome relationship due to incomplete information: for any given individual, a posttreatment confounder is observed under the actual treatment condition while missing under the counterfactual treatment condition. This paper proposes a new sensitivity analysis strategy for handling posttreatment confounding and incorporates it into weighting-based causal mediation analysis. The key is to obtain the conditional distribution of the posttreatment confounder under the counterfactual treatment as a function of not only pretreatment covariates but also its counterpart under the actual treatment. The sensitivity analysis then generates a bound for the natural indirect effect and that for the natural direct effect over a plausible range of the conditional correlation between the posttreatment confounder under the actual and that under the counterfactual conditions. Implemented through either imputation or integration, the strategy is suitable for binary as well as continuous measures of posttreatment confounders. Simulation results demonstrate major strengths and potential limitations of this new solution. A reanalysis of the National Evaluation of Welfare-to-Work Strategies (NEWWS) Riverside data reveals that the initial analytic results are sensitive to omitted posttreatment confounding.
- 9 April 2021
- Published by Wiley in Genetic Epidemiology
- Vol. 45 (4) , 353-371
A robust two‐sample transcriptome‐wide Mendelian randomization method integrating GWAS with multi‐tissue eQTL summary statistics
By treating genetic variants as instrumental variables (IVs), two‐sample Mendelian randomization (MR) methods detect genetically regulated risk exposures for complex diseases using only summary statistics. When considering gene expression as exposure in transcriptome‐wide MR (TWMR) analyses, the eQTLs (expression‐quantitative‐trait‐loci) may have pleiotropic effects or be correlated with variants that have effects on disease not via expression, and the presence of those invalid IVs would lead to biased inference. Moreover, the number of eQTLs as IVs for a gene is generally limited, making the detection of invalid IVs challenging. We propose a method, “MR‐MtRobin,” for accurate TWMR inference in the presence of invalid IVs. By leveraging multi‐tissue eQTL data in a mixed model, the proposed method makes identifiable the IV‐specific random effects due to pleiotropy from estimation errors of eQTL summary statistics, and can provide accurate inference on the dependence (fixed effects) between eQTL and GWAS (genome‐wide association study) effects in the presence of invalid IVs. Moreover, our method can improve power and precision in inference by selecting cross‐tissue eQTLs as IVs that have improved consistency of effects across eQTL and GWAS data. We applied MR‐MtRobin to detect genes associated with schizophrenia risk by integrating summary‐level data from the Psychiatric Genomics Consortium and the Genotype‐Tissue Expression project (V8).
- 9 April 2021
- Published by Wiley in Genetic Epidemiology
- Vol. 45 (4) , 353-371
A robust two‐sample transcriptome‐wide Mendelian randomization method integrating GWAS with multi‐tissue eQTL summary statistics
By treating genetic variants as instrumental variables (IVs), two‐sample Mendelian randomization (MR) methods detect genetically regulated risk exposures for complex diseases using only summary statistics. When considering gene expression as exposure in transcriptome‐wide MR (TWMR) analyses, the eQTLs (expression‐quantitative‐trait‐loci) may have pleiotropic effects or be correlated with variants that have effects on disease not via expression, and the presence of those invalid IVs would lead to biased inference. Moreover, the number of eQTLs as IVs for a gene is generally limited, making the detection of invalid IVs challenging. We propose a method, “MR‐MtRobin,” for accurate TWMR inference in the presence of invalid IVs. By leveraging multi‐tissue eQTL data in a mixed model, the proposed method makes identifiable the IV‐specific random effects due to pleiotropy from estimation errors of eQTL summary statistics, and can provide accurate inference on the dependence (fixed effects) between eQTL and GWAS (genome‐wide association study) effects in the presence of invalid IVs. Moreover, our method can improve power and precision in inference by selecting cross‐tissue eQTLs as IVs that have improved consistency of effects across eQTL and GWAS data. We applied MR‐MtRobin to detect genes associated with schizophrenia risk by integrating summary‐level data from the Psychiatric Genomics Consortium and the Genotype‐Tissue Expression project (V8).